Comparison Chart Harmony Biosciences Holdings, Inc.

HRMY

US4131971040

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	HARMONY BIOSCIENCES HOLDINGS, INC.	Other Pharmaceuticals	+4.13%	+12.86%	+15.75%	+18.93%	-16.59%	2.29B

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-05 pm EST			5-day change	1st Jan Change
39.83 ^USD	+4.13%		+12.86%	+15.75%

Dec. 01	Mizuho Raises Price Target on Harmony Biosciences Holdings to $46 From $39, Keeps Outperform Rating	MT
Nov. 24	Harmony Biosciences to Submit NDA for Narcolepsy Treatment Following Trial Results	MT

Comparison Chart Harmony Biosciences Holdings, Inc.

Equities

HRMY

US4131971040

Pharmaceuticals

Compared values

Technical Rankings Surperformance